Resistance rates to ciprofloxacin (CIP), erythromycin (ERY) and clindamycin (CLI) remained on a very high level with little fluctuation, whereas the already low rates for doxycycline (DOX), rifampicin (RAM) and quinupristin/dalfopristin (SYN) tended to decline.